Epsilon M&A Deal Report - Proteor

Transaction Multiples for the Valuation of Private Companies

Private Group backed by Ardian Growth and BNP Paribas Développement > Proteor

Announced Date : 11 December 2020

Type : OBO (Owner Buy Out)

Deal Value : Yes

Acquirer : Private Group backed by Ardian Growth and BNP Paribas Développement

Target Proteor

Target Country France

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Proteor operates in the design, manufacturing and marketing of components and materials for prosthetics and orthotics.

> Filed more than 100 patents since its creation.

No EMAT : 106378

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
31/07/2020	Bastide le Confort Médical	Technologies Medicales à Domicile (TMAD)	France	0
29/07/2020	Bastide le Confort Medical	Keylab Medical	Spain	0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database